Good Outcomes in Therapy of Fusariosis Depend on Both an Effective Drug and the Host.

Winston, Drew J; Young, Patricia A; Schlamm, Haran T; Schiller, Gary J

Winston, Drew J; Young, Patricia A; Schlamm, Haran T; Schiller, Gary J.

Affiliation

Winston DJ; Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
Young PA; Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles (UCLA), Los Angeles, California, USA.
Schlamm HT; H. T. S. Pharma Consulting, San Diego, California, USA.
Schiller GJ; Division of Hematology-Oncology, Department of Medicine, Center for Health Sciences, University of California, Los Angeles (UCLA), Los Angeles, California, USA.

Clin Infect Dis ; 79(2): 572, 2024 Aug 16.

Article de En | MEDLINE | ID: mdl-38174352

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Fusariose / Antifongiques Limites: Humans Langue: En Journal: Clin Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google